Celcuity CELC
NASDAQ CELC
$96.14 -0.29 (-0.30%)
As of: Sep 4, 2026 · 2:21 PM EDT

Celcuity (CELC) Research & Development (2016 - 2026)

Celcuity's (CELC) quarterly Research & Development came in at $37.6 million in Q4 2025, up 12.44% YoY from $33.5 million in Q4 2024, and up 7.79% on a QoQ basis from $34.9 million in Q3 2025.

Analysis

Celcuity (CELC) Research & Development (2016 - 2026) Analysis & Trends

Celcuity (CELC) has 10 years of Research & Development data on file, last reported at $37.6 million in Q4 2025.

  • Quarterly Research & Development rose 12.44% year-over-year to $37.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $145.0 million (up 39.15% YoY) and the FY2025 annual result came in at $145.0 million, up 39.15% from the prior year.
  • Research & Development improved to $37.6 million in Q4 2025, from $34.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $40.2 million in Q2 2025 to a low of $2.2 million in Q1 2021.
  • A 5-year average of $18.5 million and a median of $15.6 million in 2023 frame the typical range for Research & Development.
  • Annual changes were most pronounced in 2021 — Research & Development jumped 640.0% — and 2022, when it tumbled 35.98%.
  • Tracing CELC's Research & Development over 5 years: stood at $5.5 million in 2021, then surged by 93.12% to $10.6 million in 2022, then soared by 70.51% to $18.1 million in 2023, then soared by 85.11% to $33.5 million in 2024, then increased by 12.44% to $37.6 million in 2025.
  • The last three Research & Development figures came in at $37.6 million (Q4 2025), $34.9 million (Q3 2025), and $40.2 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 993.80 Mn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 1.63 Bn
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn -486.00 Mn
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn 651.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 394.92 Mn
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 612.28 Mn
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 413.13 Mn
8 Royalty Pharma 28.42 Bn 27.59 Bn - 97.90 Mn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 210.03 Mn
10 Celcuity 5.27 Bn 5.27 Bn - 31.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.08 Mn
Dec 31, 2025 37.64 Mn
Sep 30, 2025 34.92 Mn
Jun 30, 2025 36.42 Mn
Mar 31, 2025 32.23 Mn
Dec 31, 2024 33.47 Mn
Sep 30, 2024 27.59 Mn
Jun 30, 2024 22.50 Mn
Mar 31, 2024 20.65 Mn
Dec 31, 2023 18.08 Mn
Sep 30, 2023 17.49 Mn
Jun 30, 2023 13.75 Mn
Mar 31, 2023 11.28 Mn
Dec 31, 2022 10.60 Mn
Sep 30, 2022 9.62 Mn
Jun 30, 2022 8.37 Mn
Mar 31, 2022 6.70 Mn
Dec 31, 2021 5.49 Mn
Sep 30, 2021 4.96 Mn
Jun 30, 2021 13.07 Mn